Plate Nº 68 · recorded November 16, 2026
Health & Medicine ResearchReported finding
Very low or high thyroid levels linked to heart death risk
In an observational study of 705,000-plus U.S. veterans, very low or very high TSH readings were linked with cardiovascular death, especially below 0.1 or above 20.
By James Calloway3 min read672 words
In brief
- The study reviewed more than 705,000 U.S. veterans treated with thyroid hormone from 2004 to 2017.
- The strongest cardiovascular-death links appeared at TSH levels below 0.1 or above 20.
- Older patients appeared particularly vulnerable to the cardiovascular risks associated with extreme TSH readings.
- Researchers published the observational analysis in JAMA Network Open; it cannot establish that levothyroxine caused the deaths.
- Regular thyroid blood tests can guide clinician-led dose adjustments, but patients should not change levothyroxine on their own.

Among more than 705,000 U.S. veterans treated with thyroid hormone, those with very low or very high thyroid-stimulating hormone (TSH) readings had a greater risk of cardiovascular death, a University of Michigan study found.
The strongest links appeared at TSH levels below 0.1 or above 20, and older patients appeared particularly vulnerable. Researchers examined medical records from 2004 through 2017 and published their findings in JAMA Network Open.
The pattern was not a simple more hormone is worse story. The clearest associations sat at both ends of the TSH range, and those group-level thresholds should not be treated as instructions for changing an individual prescription. Monitoring matters. A verdict against treatment would not.
Levothyroxine, used by millions of people with an underactive thyroid, is an effective and often essential treatment. The concern is not simply whether someone takes it, but whether the dose keeps thyroid hormone levels within a healthy range.
What did the study measure?
The University of Michigan team reviewed records from more than 705,000 U.S. veterans treated with thyroid hormone between 2004 and 2017. It asked whether blood-test results during treatment were associated with deaths from heart-related causes.
The researchers focused on TSH, a hormone signal from the brain that tells the thyroid gland how much hormone the body needs. Doctors measure TSH with a blood test to help judge whether thyroid treatment needs adjustment.
TSH is a monitoring signal rather than thyroid hormone itself. Its meaning also runs in both directions: an unusually low result can indicate too much hormone, while an unusually high result can indicate too little. That helps explain why the team examined both extremes.
Why can both ends of the range affect the heart?
The study linked abnormal TSH readings with cardiovascular mortality in two ways:
- Very low TSH: This often means the body has too much thyroid hormone. Excess hormone can make the heart race and may increase the chance of an irregular heartbeat.
- Very high TSH: This can mean the body is not receiving enough thyroid hormone. Too little hormone may raise cholesterol and change how the heart and blood vessels work.
Both extremes may create cardiovascular problems over time, which fits the pattern the researchers found.
Levothyroxine replaces the hormone normally made by the thyroid gland in the neck. That hormone helps control energy, body temperature and how quickly the heart beats. Without enough of it, people may feel exhausted, cold or unusually forgetful.
The practical target is replacement without excess. Too much replacement can push hormone levels too high; too little can leave the underlying thyroid deficiency inadequately treated.
Does levothyroxine cause cardiovascular deaths?
The study does not prove that it does. Researchers examined existing medical records rather than randomly assigning treatments, so they could not fully separate the effects of hormone levels from other illnesses, differences in care or other factors that may have influenced the results.
The population also consisted largely of U.S. veterans, which may limit how well the findings apply to everyone. The records-based design cannot establish that correcting every out-of-range reading would prevent a death, either.
That is why the result supports closer monitoring rather than a simple causal claim. The signal was strong at the extremes and in older patients. It remained observational.
What does this change for people taking levothyroxine?
Regular blood tests can show whether a dose remains suitable, and a doctor can adjust treatment when necessary. Hormone needs may change with age, weight, other medicines or changes in health, so a prescription that once fitted a patient may need review later.
People taking levothyroxine should not stop or change their dose on their own. They should follow the prescribed treatment and ask a healthcare professional when the next thyroid blood test is due.
The aim is straightforward: replace the missing hormone without giving too much or too little. The study supports checking that balance with a clinician, not self-adjustment or the claim that levothyroxine caused the deaths.
via knowridge.com (Source)
More from James Calloway
Show full bio
Staff writer covering regulation, policy and their impact on general science news at SciBeat.
411 articles
Nearby plates
- Out-of-range thyroid levels linked to higher cardiovascular death risk
- Low Testosterone Linked to 18% Higher Cancer Death Risk in 26,000-Man Study
- GLP-1 overdoses hit 25,000 a year as weight-loss drug use surges
- Why Weight-Loss Drugs Fail Some People — and What Can Be Done
- Statins after 70: STREAM trial finds stopping carries measurable risk